Qingsong Capital logo

Qingsong Capital

Asia, Beijing, China, Beijing

Description

Qingsong Capital is a an entrepreneurial private equity investment institution focusing on the field of biotechnology and medical health.

Investor Profile

Qingsong Capital has made 8 investments, with 5 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (38%)
  • Series Unknown (25%)
  • Series C (13%)
  • Seed (13%)
  • Series B (13%)

Country Focus

  • China (88%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Medical Device
  • Manufacturing
  • Clinical Trials
  • Precision Medicine
  • Oncology
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qingsong Capital frequently co-invest with?

China Industrial Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
CD Capital
Asia, Zhejiang, China, Ningbo
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
CC
Asia, Liaoning, China, Chaoyang
Co-Investments: 2
Co-Investments: 1
China Reform Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Qingsong Capital?

Suzhou Meichuang

Suzhou Shi, Jiangsu, China

Meichuang focuses on the innovative R&D, manufacturing and commercialization of high-end medical devices.

MedicalMedical Device
Series AJan 15, 2025
Amount Raised: $13,640,518
Oukejian

Nanshan, Hunan, China

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

BiotechnologyHealth CareMedical
Series AJan 13, 2025
Amount Raised: $13,641,076

Yili Pharmaceutical is a pharmaceutical R&D company.

BiotechnologyHealth CareManufacturingPharmaceutical
SeedDec 24, 2024
Amount Raised: $13,706,892
Worg Pharmaceuticals

Hangzhou, Zhejiang, China

Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.

Biotechnology
Series UnknownNov 20, 2024
Weixu Biotechnology

Hohhot, Nei Mongol, China

Weixu Biotechnology is a livestock biotechnology company that specializes in integrating livestock breeding and biomedicine.

AgricultureBiotechnologyLivestockOrganic
Series AAug 30, 2024
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
CotheraBio

Beijing, Beijing, China

CotheraBio develops innovative cancer therapies with a focus on translational oncology.

Health CareMedicalMedical DeviceOncology
Series UnknownJan 2, 2021
MEDx

Suzhou, Jiangsu, China

MEDx provides precision medicine solutions to improve clinical development.

BiotechnologyClinical TrialsHealth CareMedicalPrecision Medicine
Series BSep 28, 2020
Amount Raised: $51,380,672